Connect with DES experts to discuss CMC, analytical readiness, supply chain execution, quality, and safety strategy for advanced therapy and biologics programs.
DES can route requests to the most relevant principal based on modality, function, and program needs.
The American Society of Gene and Cell Therapy Annual Meeting is the premier event for professionals across gene and cell therapy. It brings together scientists, clinicians, biotech and pharmaceutical leaders, regulatory stakeholders, manufacturers, and industry partners to share the latest research, explore new technologies, and build meaningful connections across the field.
DES Pharma Consulting is a specialized biopharmaceutical consulting firm focused on accelerating the development, manufacturing, and commercialization of advanced therapies. Founded by industry leaders with deep experience across CMC, analytical development, supply chain, and safety, DES helps biotech and pharma teams reduce risk, improve execution, and move programs forward with confidence.
The team has supported programs from preclinical development through commercial launch across cell and gene therapies, biologics, and complex modalities, bringing practical hands-on expertise to critical decisions across the product lifecycle.
Connect directly with DES principals aligned to your program’s CMC, analytical, supply chain, quality, and safety priorities.
Bioprocess design, scale-up, and IND-enabling CMC strategy across advanced therapy and biologics programs.
